Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Brafem1/Cya
Common Name:
Braf-KO
Product ID:
S-KO-00718
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Braf-KO
Strain ID
KOCMP-109880-Braf-B6J-VA
Gene Name
Braf
Product ID
S-KO-00718
Gene Alias
9930012E13Rik; B-raf; Braf-2; Braf2; C230098H17; D6Ertd631e
Background
C57BL/6JCya
NCBI ID
109880
Modification
Conventional knockout
Chromosome
6
Phenotype
MGI:88190
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Brafem1/Cya mice (Catalog S-KO-00718) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000002487
NCBI RefSeq
NM_139294
Target Region
Exon 5
Size of Effective Region
~0.1 kb
Detailed Document
Click here to download >>
Overview of Gene Research
BRAF, also known as B-Raf proto-oncogene, encodes a cytoplasmic serine/threonine kinase. It plays a key role in regulating the mitogen-activated protein kinase (MAPK) signal transduction pathway, which is crucial for cell proliferation, differentiation, apoptosis, and senescence [4,5].

BRAF is frequently mutated in many cancers. In melanoma, about 40-50% of cases have BRAF mutations, mostly at codon 600 (e.g., V600E), leading to constitutive activation of the MAPK pathway [1,6]. In colorectal cancer (CRC), BRAF mutation is present in about 10% of patients, associated with poor response to chemotherapy [3]. In non-small-cell lung cancer (NSCLC), BRAF mutations are found in 1%-2% of adenocarcinoma, commonly in never-smokers and women [7]. BRAF inhibitors have shown promise in treating BRAF-mutated cancers, but resistance mechanisms often develop [1,3,8,9]. For example, in melanoma, resistance may occur via reactivation of MAPK through CRAF/COT overexpression [9]. Also, BRAF mutational heterogeneity exists in melanoma, which may affect the indication of BRAF/MEK inhibitors [2].

In conclusion, BRAF is a critical component of the MAPK pathway. Its mutations are associated with the development and progression of multiple cancers, including melanoma, CRC, and NSCLC. Studies on BRAF-mutated cancers, especially those using gene-targeted therapies, have provided insights into the role of BRAF in cancer pathogenesis and potential treatment strategies. Understanding BRAF and its mutations is essential for developing more effective cancer therapies.

References:

1. Castellani, Giorgia, Buccarelli, Mariachiara, Arasi, Maria Beatrice, Lintas, Carla, Tabolacci, Claudio. 2023. BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers. In Cancers, 15, . doi:10.3390/cancers15164026. https://pubmed.ncbi.nlm.nih.gov/37627054/

2. Ito, Takamichi, Tanaka, Yuka, Murata, Maho, Furue, Kazuhisa, Furue, Masutaka. 2021. BRAF Heterogeneity in Melanoma. In Current treatment options in oncology, 22, 20. doi:10.1007/s11864-021-00818-3. https://pubmed.ncbi.nlm.nih.gov/33558987/

3. Aiman, Wajeeha, Ali, Muhammad Ashar, Jumean, Samer, Guron, Gunwant, Shaaban, Hamid. 2023. BRAF Inhibitors in BRAF-Mutated Colorectal Cancer: A Systematic Review. In Journal of clinical medicine, 13, . doi:10.3390/jcm13010113. https://pubmed.ncbi.nlm.nih.gov/38202120/

4. Loo, Eric, Khalili, Parisa, Beuhler, Karen, Siddiqi, Imran, Vasef, Mohammad A. . BRAF V600E Mutation Across Multiple Tumor Types: Correlation Between DNA-based Sequencing and Mutation-specific Immunohistochemistry. In Applied immunohistochemistry & molecular morphology : AIMM, 26, 709-713. doi:10.1097/PAI.0000000000000516. https://pubmed.ncbi.nlm.nih.gov/29271794/

5. Liu, Haotian, Nazmun, Nahar, Hassan, Shafat, Liu, Xinyue, Yang, Jilong. 2020. BRAF mutation and its inhibitors in sarcoma treatment. In Cancer medicine, 9, 4881-4896. doi:10.1002/cam4.3103. https://pubmed.ncbi.nlm.nih.gov/32476297/

6. Pelosi, Elvira, Castelli, Germana, Testa, Ugo. 2024. Braf-Mutant Melanomas: Biology and Therapy. In Current oncology (Toronto, Ont.), 31, 7711-7737. doi:10.3390/curroncol31120568. https://pubmed.ncbi.nlm.nih.gov/39727691/

7. Yan, Ningning, Guo, Sanxing, Zhang, Huixian, Shen, Shujing, Li, Xingya. 2022. BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective. In Frontiers in oncology, 12, 863043. doi:10.3389/fonc.2022.863043. https://pubmed.ncbi.nlm.nih.gov/35433454/

8. Foth, Mona, McMahon, Martin. 2021. Autophagy Inhibition in BRAF-Driven Cancers. In Cancers, 13, . doi:10.3390/cancers13143498. https://pubmed.ncbi.nlm.nih.gov/34298710/

9. Alqathama, Aljawharah. 2020. BRAF in malignant melanoma progression and metastasis: potentials and challenges. In American journal of cancer research, 10, 1103-1114. doi:. https://pubmed.ncbi.nlm.nih.gov/32368388/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest